ABPI calls for a “world-class NHS” with 2017 General Election Manifesto

April 27, 2017
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Theresa May, general election

With Theresa May’s announcement of a snap election in earlier this month, the life sciences industry erupted into fiery discourse. …

astrazeneca_building_white

AZ’s Tagrisso continues successes with EU approval

April 26, 2017
Research and Development, Sales and Marketing AstraZeneca, EU, European Commission, NSCLC, Tagrisso

More good news for AstraZeneca’s Tagrisso (osimertinib), as the company announces that the European Commission has granted the drug full …

FDA condemns 14 companies selling fraudulent cancer ‘cures’ online

April 26, 2017
Research and Development, Sales and Marketing Cancer, FDA

The FDA has struck out against a wave of companies offering cancer treatments online which fraudulently claim to be able …

shutterstock_95714119

Research identifies marker for aggressive ovarian cancer

April 26, 2017
Research and Development Cancer, ovarian cancer

Scientists have identified a marker which they believe can inform whether a tumour will become more aggressive and pose a …

shutterstock_92671375

Sanofi launches lawsuit against Mylan over “illegal business practices”

April 26, 2017
Research and Development, Sales and Marketing Auvi-Q, Mylan, Sanofi, epipen, lawsuit

In a move that is sure to pile even more pressure onto Mylan after the company’s recent woes, Sanofi has …

pharmafocus_may_cover

The May 2017 issue of Pharmafocus is now live!

April 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus

The latest edition of Pharmafocus is available to read now! In this issue we delve into pharma’s reaction to the …

Rasna Therapeutics appoints new CEO

April 25, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Rasna Therapeutics, the UK-based biotech that specialises in developing treatments for leukaemia, has announced the appointment of a new CEO. …

uk_location_in_the_eu_2016

Pharma industry calls for EMA relocation by June in open EFPIA letter

April 25, 2017
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA

Heads of research from 19 of the biggest players in the industry have called for a decision to be made …

stent

Indian government goes to war over 75% stent price reduction

April 25, 2017
Manufacturing and Production India, cardiac stents

The National Pharmaceutical Pricing Authority (NPPA), India’s drug pricing regulator, moved to lower the price of the newest generation of …

EMA gives positive opinion on Biogen’s spinal muscular atrophy drug Spinraza

April 25, 2017
Manufacturing and Production, Sales and Marketing Biogen, Ionis, Spinraza, spinal muscular atrophy

Biogen has revealed that Spinraza (nusinersen), its treatment for spinal muscular atrophy (SMA) , has received a positive opinion from …

surgery

Quarter of cancer patients visit GP three times with no diagnosis

April 25, 2017
Manufacturing and Production, Research and Development Cancer, GP, NHS, oncology

A recent study, published in the British Journal of General Practice, has found that 23% of those suffering from cancer …

japan-112722_640

Japanese pharma expects 17% growth throughout 2017

April 25, 2017
Manufacturing and Production CPhI, Japan

Pharma companies attending CPhI Japan are expecting a 17% growth of the country’s market throughout the year, according to data …

mental-health-2019924_640

Five crucial facts about mental health

April 24, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, anxiety, depression, mental health, world health day

7 April marked this year’s World Health Day, and for 2017 the WHO selected depression as the annual focus. Prevalent …

lavalbldg1806696_853705

Psoriasis drug Siliq will be cheapest in class, Valeant reveals

April 24, 2017
Sales and Marketing Siliq, Valeant, psoriasis

Canadian pharmaceutical firm Valeant has announced the list price for its psoriasis treat Siliq (brodalumab) will stand at $3,500 a …

shutterstock_311949818

Breakthrough multiple sclerosis research sheds light on cause of the disease

April 24, 2017
Research and Development, Sales and Marketing multiple sclerosis

Researchers from the Universities of Exeter and Alberta have identified a protein in the brain which they believe could be …

janssen_latest_logo_on_sign

Janssen acquires over 90% of Actelion

April 24, 2017
Sales and Marketing Actelion, Janssen

Actelion has revealed that, following the wrap of its $30 billion deal in January, Janssen Holding has acquired 92.51% of …

ema_building_face_web

EU recommendation for Sanofi and Regeneron’s arthritis treatment

April 24, 2017
Sales and Marketing Kevzara, NICE, sarilumab

Sanofi and Regeneron are celebrating the news that their treatment Kevzara (sarilumab) has received a positive opinion from the EMA’s …

England “really is not a good place” to get cancer, BMS UK General Manager says

April 24, 2017
Medical Communications, Research and Development, Sales and Marketing BMS, NICE, opdivo

Bristol-Myers Squibb’s UK General Manager Ben Hickey has slammed NICE over its assessment criteria and process in recommending access to …

dna_manufacture

Applied DNA Sciences agrees deal for bulk DNA manufacturing

April 21, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing Applied DNA sciences, DNA manufacture

In a deal that sounds more like something to come out of a science-fiction novel, Applied DNA Sciences has agreed …

cough_syrup

FDA restricts administration of strong pain killers to children

April 21, 2017
Medical Communications, Sales and Marketing FDA, opioid

The FDA has announced that it will require medication including codeine and tramadol, two high-strength painkillers, to have its strongest …

The Gateway to Local Adoption Series

Latest content